Jefferies Financial Group Raises LHC Group (LHCG) Price Target to $130.00

LHC Group (NASDAQ:LHCG) had its price target raised by Jefferies Financial Group from $125.00 to $130.00 in a research note issued to investors on Thursday morning, The Fly reports. The firm currently has a buy rating on the health services provider’s stock.

A number of other research analysts also recently issued reports on LHCG. Zacks Investment Research downgraded LHC Group from a hold rating to a sell rating in a report on Thursday, May 2nd. BidaskClub downgraded LHC Group from a buy rating to a hold rating in a research note on Wednesday, March 27th. Barclays lifted their target price on LHC Group from $95.00 to $104.00 and gave the stock an equal weight rating in a research note on Thursday, March 21st. Craig Hallum lifted their price target on LHC Group from $93.00 to $114.00 and gave the stock a hold rating in a report on Friday, March 1st. They noted that the move was a valuation call. Finally, Robert W. Baird lifted their price target on LHC Group from $98.00 to $120.00 and gave the stock a neutral rating in a report on Monday, March 4th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of $118.50.

Shares of LHCG traded down $2.01 during trading hours on Thursday, hitting $114.12. 25,286 shares of the stock traded hands, compared to its average volume of 302,585. The company has a quick ratio of 1.78, a current ratio of 1.57 and a debt-to-equity ratio of 0.21. LHC Group has a 1-year low of $72.10 and a 1-year high of $116.74. The firm has a market capitalization of $3.62 billion, a PE ratio of 32.15, a price-to-earnings-growth ratio of 1.96 and a beta of 0.87.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.08. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. The firm had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. Analysts anticipate that LHC Group will post 4.3 EPS for the current year.

In other LHC Group news, CEO Keith G. Myers sold 11,558 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $108.83, for a total transaction of $1,257,857.14. Following the completion of the transaction, the chief executive officer now directly owns 96,315 shares of the company’s stock, valued at $10,481,961.45. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Donald Dwayne Stelly sold 15,151 shares of the stock in a transaction on Monday, March 11th. The shares were sold at an average price of $107.06, for a total value of $1,622,066.06. Following the transaction, the chief operating officer now directly owns 92,065 shares of the company’s stock, valued at $9,856,478.90. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 117,876 shares of company stock valued at $12,762,540. 5.20% of the stock is currently owned by corporate insiders.

Several large investors have recently bought and sold shares of LHCG. Norges Bank purchased a new stake in shares of LHC Group during the fourth quarter worth $51,535,000. Victory Capital Management Inc. purchased a new stake in shares of LHC Group in the first quarter worth $42,215,000. FMR LLC raised its position in shares of LHC Group by 24.9% in the fourth quarter. FMR LLC now owns 1,123,833 shares of the health services provider’s stock worth $105,506,000 after buying an additional 224,124 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in shares of LHC Group in the first quarter worth $20,374,000. Finally, Oak Ridge Investments LLC purchased a new stake in shares of LHC Group in the first quarter worth $14,838,000. Hedge funds and other institutional investors own 92.78% of the company’s stock.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Further Reading: Net Margin

The Fly

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.